Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
3.236
+0.076 (2.41%)
Nov 21, 2024, 10:51 AM EST - Market open
Atea Pharmaceuticals Analyst Ratings
Total Analysts
1
Consensus Rating
Hold
Price Target
$6.88
Upside
+112.61%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Sell → Hold Upgrades $2 → $6.88 | Sell → Hold | Upgrades | $2 → $6.88 | +112.61% | Aug 13, 2024 |
| JP Morgan | JP Morgan | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Aug 10, 2023 |
| JP Morgan | JP Morgan | Hold Maintains $12 → $8 | Hold | Maintains | $12 → $8 | +147.22% | Mar 16, 2023 |
| SVB Leerink | SVB Leerink | Hold Maintains $8 → $6 | Hold | Maintains | $8 → $6 | +85.41% | Jan 27, 2023 |
| Morgan Stanley | Morgan Stanley | Sell Maintains $7 → $4 | Sell | Maintains | $7 → $4 | +23.61% | Jan 24, 2023 |
| Morgan Stanley | Morgan Stanley | Sell Maintains $6 → $7 | Sell | Maintains | $6 → $7 | +116.32% | Aug 15, 2022 |
| JP Morgan | JP Morgan | Hold Maintains $10 → $8 | Hold | Maintains | $10 → $8 | +147.22% | Mar 2, 2022 |
| SVB Leerink | SVB Leerink | Hold Maintains $10 → $9 | Hold | Maintains | $10 → $9 | +178.12% | Mar 1, 2022 |
| SVB Leerink | SVB Leerink | Hold Maintains $11 → $10 | Hold | Maintains | $11 → $10 | +209.02% | Feb 16, 2022 |
| Morgan Stanley | Morgan Stanley | Hold → Sell Downgrades $14 → $7 | Hold → Sell | Downgrades | $14 → $7 | +116.32% | Jan 6, 2022 |
| SVB Leerink | SVB Leerink | Buy → Hold Downgrades $11 | Buy → Hold | Downgrades | $11 | +239.93% | Nov 18, 2021 |
| SVB Leerink | SVB Leerink | Buy Maintains $60 → $20 | Buy | Maintains | $60 → $20 | +518.05% | Oct 20, 2021 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades $61 → $16 | Buy → Hold | Downgrades | $61 → $16 | +394.44% | Oct 20, 2021 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $55 | Buy → Hold | Downgrades | $55 | +1,599.63% | Oct 5, 2021 |
| SVB Leerink | SVB Leerink | Buy Initiates $60 | Buy | Initiates | $60 | +1,754.14% | Sep 9, 2021 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $35 → $37 | Buy | Maintains | $35 → $37 | +1,043.39% | Aug 18, 2021 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.